Cargando…

Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis

Recently, the gut microbiota has been recognized as an obvious active player in addition to liver steatosis/steatohepatitis in the pathophysiological mechanisms of the development of hepatocellular carcinoma (HCC), even in the absence of cirrhosis. Evidence from clinical and experimental studies sho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liakina, Valentina, Strainiene, Sandra, Stundiene, Ieva, Maksimaityte, Vaidota, Kazenaite, Edita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376773/ https://www.ncbi.nlm.nih.gov/pubmed/36158907 http://dx.doi.org/10.4254/wjh.v14.i7.1277

Ejemplares similares

Menstrual cycle abnormalities in women with inflammatory bowel disease and effects of biological therapy on gynecological pathology
por: Malinauskiene, Vaidota, et al.
Publicado: (2023)

Mucosa-associated lymphoid tissue lymphoma simulating Crohn’s disease: A case report
por: Stundiene, Ieva, et al.
Publicado: (2020)

Metastatic multifocal melanoma of multiple organ systems: A case report
por: Maksimaityte, Vaidota, et al.
Publicado: (2022)

Multi-organ IgG4-related disease continues to mislead clinicians: A case report and literature review
por: Strainiene, Sandra, et al.
Publicado: (2020)

Effects of COVID-19 on the liver: The experience of a single center
por: Liakina, Valentina, et al.
Publicado: (2022)

Management of Flood syndrome: What can we do better?
por: Strainiene, Sandra, et al.
Publicado: (2021)

Paraneoplastic Phenomena of Disseminated Intravascular Coagulopathy in Hepatic Angiosarcoma – Rare, Challenging and Fatal. Case Report and Literature Review
por: Strainienė, Sandra, et al.
Publicado: (2021)

Gastrectomy impact on the gut microbiome in patients with gastric cancer: A comprehensive review
por: Maksimaityte, Vaidota, et al.
Publicado: (2021)

Complicated course of biliary inflammatory myofibroblastic tumor mimicking hilar cholangiocarcinoma: A case report and literature review
por: Strainiene, Sandra, et al.
Publicado: (2021)

Nivolumab-induced tumour-like gastritis: A case report
por: Cijauskaite, Elena, et al.
Publicado: (2023)

Liver cirrhosis and left ventricle diastolic dysfunction: Systematic review
por: Stundiene, Ieva, et al.
Publicado: (2019)

Crohn’s disease in human immunodeficiency virus-infected patient: A case report
por: Vinikaite, Ausra, et al.
Publicado: (2023)

Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice
por: Yamada, Shoji, et al.
Publicado: (2018)

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
por: Rios, Rafael S., et al.
Publicado: (2021)

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
por: Weinmann, Arndt, et al.
Publicado: (2015)

Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
por: Ramai, Daryl, et al.
Publicado: (2021)

Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
por: Tovo, Cristiane Valle, et al.
Publicado: (2023)

Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
por: Yu, Junjie, et al.
Publicado: (2023)

Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma
por: Shiina, Shuichiro, et al.
Publicado: (2023)

Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
por: Kumar, Rahul, et al.
Publicado: (2020)

The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais
por: Sobhonslidsuk, Abhasnee, et al.
Publicado: (2018)

Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol
por: Yang, Ming, et al.
Publicado: (2023)

Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma: Implications for Lycopene Intervention
por: Ip, Blanche C., et al.
Publicado: (2013)

Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Kessler, Sonja M., et al.
Publicado: (2014)

Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
por: Mouries, Juliette, et al.
Publicado: (2019)

Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites
por: Zhu, Mingzhe, et al.
Publicado: (2023)

Gut microbiota and host Cyp450s co-contribute to pharmacokinetic variability in mice with non-alcoholic steatohepatitis: Effects vary from drug to drug
por: Guo, Jing, et al.
Publicado: (2021)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021)

Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice
por: Kasai, Kaichi, et al.
Publicado: (2023)

Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
por: Cholankeril, George, et al.
Publicado: (2017)

Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma
por: Zheng, Ruipeng, et al.
Publicado: (2020)

Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy
por: Luo, Wenyu, et al.
Publicado: (2022)

Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis
por: Yang, Chao, et al.
Publicado: (2021)

Val‐Val‐Tyr‐Pro protects against non‐alcoholic steatohepatitis in mice by modulating the gut microbiota and gut‐liver axis activation
por: Xie, Xinshu, et al.
Publicado: (2021)

Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas
por: Kakehashi, Anna, et al.
Publicado: (2017)

Nrf2-mediated anti-oxidant effects contribute to suppression of non-alcoholic steatohepatitis-associated hepatocellular carcinoma in murine model
por: Yamada, Shoji, et al.
Publicado: (2018)

Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis
por: Witjes, Julia J., et al.
Publicado: (2020)

Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
por: Gillard, Justine, et al.
Publicado: (2021)

Lactiplantibacillus plantarum LPJZ-658 Improves Non-Alcoholic Steatohepatitis by Modulating Bile Acid Metabolism and Gut Microbiota in Mice
por: Liu, Liming, et al.
Publicado: (2023)

Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma
por: Takakura, Kazuki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8uji5a9i21c83aqbebn1ntmsn3